Skip to main content
Erschienen in: Journal of Diabetes & Metabolic Disorders 2/2018

25.10.2018 | Research Article

Adherence to medications, self-care activity, and HbA1c status among patients with type 2 diabetes living in an urban area of Iran

verfasst von: Amir Jafarian-Amirkhizi, Amir Sarayani, Kheirollah Gholami, Maryam Taghizadeh-Ghehi, Kazem Heidari, Aarefeh Jafarzadeh-Kohneloo, Donald E. Morisky

Erschienen in: Journal of Diabetes & Metabolic Disorders | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Appropriate pharmacotherapy, self-care and adherence to medications are crucial to diabetes control. We aimed to study the diabetes care and glycemic control in patients with type two diabetes living in an urban area of Iran.

Methods

In this cross-sectional study, patients with type 2 diabetes who attended a referral university affiliated community pharmacy and an accredited pathobiology laboratory in the 17th district of Tehran were evaluated. Data including demographics, medical and drug history were collected. Self-care activity (Diabetes Self-care Activity Measurement Scale) and medication adherence (8-item Morisky Medication Adherence scale) were also assessed. After completing the questionnaires, the patients were referred to the laboratory for Hemoglobin A1c test.

Results

Three hundred forty-eight patients (60.3% females) were recruited. The mean (SD) of patients’ age was 55.82 (12.72) and 75.3%of them were Illiterate or had primary education. Mean (SD) of Hemoglobin A1c levels was 8.39 (2.03) and 33% of patients had levels higher than 9%. Among study patients, 186 (53.4%) patients received monotherapy for diabetes type 2 and 200 (57.5%) patients had low adherence to medications. Physical activity, blood glucose self-monitoring and foot care were domains of self-care with the fewest practice. Re-using a pen or syringe needle more than once was reported by 83% of patients and mean (SD) time of re-using a pen needle was 9.11 (8.74).

Conclusion

Poor glycemic control, low medication adherence, inadequate self-care activities, signals of inappropriate pharmacotherapy and inadequate medical visits and monitoring in the study patients highlight the importance of providing accessible and affordable health care services in the region. Moreover, educational needs of the patients should be considered especially in an area in which the majority of patients are old and illiterate and have low socioeconomic status.
Literatur
1.
Zurück zum Zitat King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–31.CrossRefPubMed King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–31.CrossRefPubMed
2.
Zurück zum Zitat Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311–21.CrossRefPubMed Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311–21.CrossRefPubMed
3.
Zurück zum Zitat Noshad S, Afarideh M, Heidari B, Mechanick JI, Esteghamati A. Diabetes Care in Iran: where we stand and where we are headed. Ann Glob Health. 2015;81:839–50.CrossRefPubMed Noshad S, Afarideh M, Heidari B, Mechanick JI, Esteghamati A. Diabetes Care in Iran: where we stand and where we are headed. Ann Glob Health. 2015;81:839–50.CrossRefPubMed
4.
Zurück zum Zitat Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care. 2008;31:96–8.CrossRefPubMed Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care. 2008;31:96–8.CrossRefPubMed
5.
Zurück zum Zitat Haghdoost A, Rezazadeh-Kermani M, Sadghirad B, Baradaran H. Prevalence of type 2 diabetes in the Islamic Republic of Iran: systematic review and meta-analysis. East Mediterr Health J. 2009;15:591.CrossRefPubMed Haghdoost A, Rezazadeh-Kermani M, Sadghirad B, Baradaran H. Prevalence of type 2 diabetes in the Islamic Republic of Iran: systematic review and meta-analysis. East Mediterr Health J. 2009;15:591.CrossRefPubMed
6.
Zurück zum Zitat Rashedi V, Asadi-Lari M, Delbari A, Fadayevatan R, Borhaninejad V, Foroughan M. Prevalence of diabetes type 2 in older adults: findings from a large population-based survey in Tehran, Iran (Urban HEART-2). Diabetes Metab Syndr. 2017. Rashedi V, Asadi-Lari M, Delbari A, Fadayevatan R, Borhaninejad V, Foroughan M. Prevalence of diabetes type 2 in older adults: findings from a large population-based survey in Tehran, Iran (Urban HEART-2). Diabetes Metab Syndr. 2017.
7.
Zurück zum Zitat American Diabetes Association Standards of Medical Care in Diabetes—2017: Glycemic targets. Diabetes Care. 2017;40:S48–56. American Diabetes Association Standards of Medical Care in Diabetes2017: Glycemic targets. Diabetes Care. 2017;40:S48–56.
8.
Zurück zum Zitat Sarayani A, Jahangard-Rafsanjani Z, Hadjibabaie M, Ahmadvand A, Javadi M, Gholami K. A comprehensive review of adherence to diabetes and cardiovascular medications in Iran; implications for practice and research. J Diabetes Metab Disord. 2013;12:57.CrossRefPubMedCentralPubMed Sarayani A, Jahangard-Rafsanjani Z, Hadjibabaie M, Ahmadvand A, Javadi M, Gholami K. A comprehensive review of adherence to diabetes and cardiovascular medications in Iran; implications for practice and research. J Diabetes Metab Disord. 2013;12:57.CrossRefPubMedCentralPubMed
9.
Zurück zum Zitat Delavari A. Quality of care of diabetes mellitus type II patients in Iran. Arch Iran Med. 2009;12:492–5.PubMed Delavari A. Quality of care of diabetes mellitus type II patients in Iran. Arch Iran Med. 2009;12:492–5.PubMed
10.
Zurück zum Zitat Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M. Adherence to glyburide and metformin and associated factors in type 2 diabetes in Isfahan, Iran. Iran J Pharm Res. 2011;10:933–9.PubMedCentralPubMed Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M. Adherence to glyburide and metformin and associated factors in type 2 diabetes in Isfahan, Iran. Iran J Pharm Res. 2011;10:933–9.PubMedCentralPubMed
11.
Zurück zum Zitat Kheirandish M, Mahboobi H, Yazdanparast M, Kamal MA. Challenges related to glycemic control in type 2 diabetes mellitus patients. Curr Drug Metab. 2017;18:157–62.CrossRefPubMed Kheirandish M, Mahboobi H, Yazdanparast M, Kamal MA. Challenges related to glycemic control in type 2 diabetes mellitus patients. Curr Drug Metab. 2017;18:157–62.CrossRefPubMed
12.
Zurück zum Zitat Sarayani A, Rashidian A, Gholami K. Low utilisation of diabetes medicines in Iran, despite their affordability (2000–2012): a time-series and benchmarking study. BMJ Open. 2014;4. Sarayani A, Rashidian A, Gholami K. Low utilisation of diabetes medicines in Iran, despite their affordability (2000–2012): a time-series and benchmarking study. BMJ Open. 2014;4.
13.
Zurück zum Zitat Shahandeh K, Majdzadeh S, Kamali S, Pourmalek F, JamshidI E, Ghajarieh Sepanlou S, et al. Analysis of demographic and socioeconomic determinants of 17th zone Tehran: Tehran population lab region. Iran J Diabetes Metabol. 2004;3:5–10. Shahandeh K, Majdzadeh S, Kamali S, Pourmalek F, JamshidI E, Ghajarieh Sepanlou S, et al. Analysis of demographic and socioeconomic determinants of 17th zone Tehran: Tehran population lab region. Iran J Diabetes Metabol. 2004;3:5–10.
14.
Zurück zum Zitat Larijani B, Mortaz Hejri S, Pour-Ebrahim R, Nouri M, Heshmat R, Shooshtarizadeh P, et al. Evaluation of type 2 diabetes and impaired fasting glucose (IFG) among 25-64 aged inhabitants of Tehran University of Medical Sciences Population lab Region. Iran J Diabetes Metabol. 2004;3:44–52. Larijani B, Mortaz Hejri S, Pour-Ebrahim R, Nouri M, Heshmat R, Shooshtarizadeh P, et al. Evaluation of type 2 diabetes and impaired fasting glucose (IFG) among 25-64 aged inhabitants of Tehran University of Medical Sciences Population lab Region. Iran J Diabetes Metabol. 2004;3:44–52.
15.
Zurück zum Zitat Ghajarieh Sepanlou S, Majdzadeh S, Kamali S, Pourmalek F, Jamshidi E, Shahandeh K. Evaluation of the household expenses per capita and the inequity in people’s economic status and healthcare services. Iran J Diabetes Metabol. 2004;3:11–20. Ghajarieh Sepanlou S, Majdzadeh S, Kamali S, Pourmalek F, Jamshidi E, Shahandeh K. Evaluation of the household expenses per capita and the inequity in people’s economic status and healthcare services. Iran J Diabetes Metabol. 2004;3:11–20.
16.
Zurück zum Zitat Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000;23:943–50.CrossRefPubMed Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000;23:943–50.CrossRefPubMed
17.
Zurück zum Zitat Jahangard-Rafsanjani Z, Sarayani A, Nosrati M, Saadat N, Rashidian A, Hadjibabaie M, et al. Effect of a community pharmacist–delivered diabetes support program for patients receiving specialty medical care: a randomized controlled trial. Diabetes Educ. 2015;41:127–35.CrossRefPubMed Jahangard-Rafsanjani Z, Sarayani A, Nosrati M, Saadat N, Rashidian A, Hadjibabaie M, et al. Effect of a community pharmacist–delivered diabetes support program for patients receiving specialty medical care: a randomized controlled trial. Diabetes Educ. 2015;41:127–35.CrossRefPubMed
18.
Zurück zum Zitat Shakibazadeh E, Rashidian A, Larijani B, Shojaeezadeh D, Forouzanfar M, Karimi Shahanjarini A. Perceived barriers and self-efficacy: impact on self-care behaviors in adults with type 2 diabetes. J Hayat. 2010;15:69–78. Shakibazadeh E, Rashidian A, Larijani B, Shojaeezadeh D, Forouzanfar M, Karimi Shahanjarini A. Perceived barriers and self-efficacy: impact on self-care behaviors in adults with type 2 diabetes. J Hayat. 2010;15:69–78.
19.
Zurück zum Zitat Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10:348–54.CrossRef Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10:348–54.CrossRef
20.
Zurück zum Zitat Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence: response to authors. J Clin Epidemiol. 2011;64:255–63.CrossRefPubMed Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence: response to authors. J Clin Epidemiol. 2011;64:255–63.CrossRefPubMed
21.
Zurück zum Zitat Dehghan M, Nayeri ND, Karimzadeh P, Iranmanesh S. Psychometric properties of the Persian version of the Morisky medication adherence scale-8. Br J Med Med Res. 2015;9:BJMMR.17345.CrossRef Dehghan M, Nayeri ND, Karimzadeh P, Iranmanesh S. Psychometric properties of the Persian version of the Morisky medication adherence scale-8. Br J Med Med Res. 2015;9:BJMMR.17345.CrossRef
22.
Zurück zum Zitat Ghanei Gheshlagh R, Ebadi A, Veisi Raygani AK, Nourozi Tabrizi K, Dalvandi A, Mahmoodi H. Determining concurrent validity of the Morisky medication adherence scale in patients with type 2 diabetes. J Rehab Res Nurs. 2015;1:24–32. Ghanei Gheshlagh R, Ebadi A, Veisi Raygani AK, Nourozi Tabrizi K, Dalvandi A, Mahmoodi H. Determining concurrent validity of the Morisky medication adherence scale in patients with type 2 diabetes. J Rehab Res Nurs. 2015;1:24–32.
23.
Zurück zum Zitat WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment 2017. Oslo, Norway; 2017. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment 2017. Oslo, Norway; 2017.
24.
Zurück zum Zitat Bonakdaran S, Ebrahimzadeh S, Noghabi SH. Cardiovascular disease and risk factors in patients with type 2 diabetes mellitus in Mashhad, Islamic Republic of Iran. East Mediterr Health J. 2011;17:640–6.CrossRefPubMed Bonakdaran S, Ebrahimzadeh S, Noghabi SH. Cardiovascular disease and risk factors in patients with type 2 diabetes mellitus in Mashhad, Islamic Republic of Iran. East Mediterr Health J. 2011;17:640–6.CrossRefPubMed
25.
Zurück zum Zitat Bergman U, Sjöqvist F. Measurement of drug utilization in Sweden: methodological and clinical implications. Acta Med Scand. 1984;215:15–22.CrossRef Bergman U, Sjöqvist F. Measurement of drug utilization in Sweden: methodological and clinical implications. Acta Med Scand. 1984;215:15–22.CrossRef
26.
Zurück zum Zitat Lee W-Y, Ahn J, Kim J-H, Hong Y-P, Hong SK, Kim YT, et al. Reliability and validity of a self-reported measure of medication adherence in patients with type 2 diabetes mellitus in Korea. J Int Med Res. 2013;41:1098–110.CrossRefPubMed Lee W-Y, Ahn J, Kim J-H, Hong Y-P, Hong SK, Kim YT, et al. Reliability and validity of a self-reported measure of medication adherence in patients with type 2 diabetes mellitus in Korea. J Int Med Res. 2013;41:1098–110.CrossRefPubMed
27.
Zurück zum Zitat Sakthong P, Chabunthom R, Charoenvisuthiwongs R. Psychometric properties of the Thai version of the 8-item Morisky medication adherence scale in patients with type 2 diabetes. Ann Pharmacother. 2009;43:950–7.CrossRefPubMed Sakthong P, Chabunthom R, Charoenvisuthiwongs R. Psychometric properties of the Thai version of the 8-item Morisky medication adherence scale in patients with type 2 diabetes. Ann Pharmacother. 2009;43:950–7.CrossRefPubMed
28.
Zurück zum Zitat Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25:1015–21.CrossRefPubMed Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25:1015–21.CrossRefPubMed
29.
Zurück zum Zitat Tandon S, Chew M, Eklu-Gadegbeku CK, Shermock KM, Morisky DE. Validation and psychometric properties of the 8-item Morisky medication adherence scale (MMAS-8) in type 2 diabetes patients in sub-Saharan Africa. Diabetes Res Clin Pract. 2015;110:129–36.CrossRefPubMed Tandon S, Chew M, Eklu-Gadegbeku CK, Shermock KM, Morisky DE. Validation and psychometric properties of the 8-item Morisky medication adherence scale (MMAS-8) in type 2 diabetes patients in sub-Saharan Africa. Diabetes Res Clin Pract. 2015;110:129–36.CrossRefPubMed
30.
Zurück zum Zitat Wang J, R-w B, Mo Y-z. Validation of the Chinese version of the eight-item Morisky medication adherence scale in patients with type 2 diabetes mellitus. J Clin Gerontol Geriatr. 2013;4:119–22.CrossRef Wang J, R-w B, Mo Y-z. Validation of the Chinese version of the eight-item Morisky medication adherence scale in patients with type 2 diabetes mellitus. J Clin Gerontol Geriatr. 2013;4:119–22.CrossRef
31.
Zurück zum Zitat Al-Majed HT, Ismael AE, Al-Khatlan HM, El-Shazly MK. Adherence of type-2 diabetic patients to treatment. Kuwait Med J. 2014;46:225–32. Al-Majed HT, Ismael AE, Al-Khatlan HM, El-Shazly MK. Adherence of type-2 diabetic patients to treatment. Kuwait Med J. 2014;46:225–32.
32.
Zurück zum Zitat García-Pérez L-E, Álvarez M, Dilla T, Gil-Guillén V, Orozco-Beltrán D. Adherence to therapies in patients with type 2 diabetes. Diabetes Ther. 2013;4:175–94.CrossRefPubMedCentralPubMed García-Pérez L-E, Álvarez M, Dilla T, Gil-Guillén V, Orozco-Beltrán D. Adherence to therapies in patients with type 2 diabetes. Diabetes Ther. 2013;4:175–94.CrossRefPubMedCentralPubMed
33.
Zurück zum Zitat Yurgin NR, Boye KS, Dilla T, Suriñach NL, Llach XB. Physician and patient management of type 2 diabetes and factors related to glycemic control in Spain. Patient Prefer Adherence. 2008;2:87–95.PubMedCentralPubMed Yurgin NR, Boye KS, Dilla T, Suriñach NL, Llach XB. Physician and patient management of type 2 diabetes and factors related to glycemic control in Spain. Patient Prefer Adherence. 2008;2:87–95.PubMedCentralPubMed
34.
Zurück zum Zitat Yekta Z, Pourali R, Aghassi MR, Ashragh N, Ravanyar L, Rahim Pour MY. Assessment of self-care practice and its associated factors among diabetic patients in urban area of Urmia, northwest of Iran. J Res Health Sci. 2011;11:33–8.PubMed Yekta Z, Pourali R, Aghassi MR, Ashragh N, Ravanyar L, Rahim Pour MY. Assessment of self-care practice and its associated factors among diabetic patients in urban area of Urmia, northwest of Iran. J Res Health Sci. 2011;11:33–8.PubMed
35.
Zurück zum Zitat Azizi F, Gouya M, Vazirian P, Dolatshahi P, Habibian S. The diabetes prevention and control programme of the Islamic Republic of Iran. East Mediterr Health J. 2003;9:1114–21.PubMed Azizi F, Gouya M, Vazirian P, Dolatshahi P, Habibian S. The diabetes prevention and control programme of the Islamic Republic of Iran. East Mediterr Health J. 2003;9:1114–21.PubMed
36.
Zurück zum Zitat Moaatari M, Rezaee K, Mostafavi H, Zare N. Outcome of multiple usages of disposable insulin syringes in insulin dependent patients referring to Shahid Motahari Clinic in Shiraz. Res Med. 2005;29:307–12. Moaatari M, Rezaee K, Mostafavi H, Zare N. Outcome of multiple usages of disposable insulin syringes in insulin dependent patients referring to Shahid Motahari Clinic in Shiraz. Res Med. 2005;29:307–12.
37.
Zurück zum Zitat Strauss K, Gols HD, Hannet I, Partanen T-M, Frid A. A pan-European epidemiologic study of insulin injection technique in patients with diabetes. Pract Diab Int. 2002;19:71–6.CrossRef Strauss K, Gols HD, Hannet I, Partanen T-M, Frid A. A pan-European epidemiologic study of insulin injection technique in patients with diabetes. Pract Diab Int. 2002;19:71–6.CrossRef
Metadaten
Titel
Adherence to medications, self-care activity, and HbA1c status among patients with type 2 diabetes living in an urban area of Iran
verfasst von
Amir Jafarian-Amirkhizi
Amir Sarayani
Kheirollah Gholami
Maryam Taghizadeh-Ghehi
Kazem Heidari
Aarefeh Jafarzadeh-Kohneloo
Donald E. Morisky
Publikationsdatum
25.10.2018
Verlag
Springer International Publishing
Erschienen in
Journal of Diabetes & Metabolic Disorders / Ausgabe 2/2018
Elektronische ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-018-0356-4

Weitere Artikel der Ausgabe 2/2018

Journal of Diabetes & Metabolic Disorders 2/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.